Skip to main content
Clinical Trials/TCTR20221027003
TCTR20221027003
Not Yet Recruiting
Phase 3

Comparison of diagnostic performance between induced sputum or endotracheal aspiration and bronchoalveolar lavage fluid in Pneumocystis jirovecii pneumonia

/A0 sites120 target enrollmentOctober 27, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
AdultImmunocompromised host
Sponsor
/A
Enrollment
120
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 27, 2022
End Date
April 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • Immunocompromised host or received immunosuppressive agent
  • Suspected pneumonia
  • Performed bronchoalveolar lavage

Exclusion Criteria

  • Not performed bronchoalveolar lavage
  • Active Covid 19 infection

Outcomes

Primary Outcomes

Not specified

Similar Trials